SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-21-014799
Filing Date
2021-01-22
Accepted
2021-01-22 16:32:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d102910dposam.htm POS AM 18029
  Complete submission text file 0001193125-21-014799.txt   19014
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-239612 | Film No.: 21546196
SIC: 2836 Biological Products, (No Diagnostic Substances)